Liver Diseases  >>  Incivek (telaprevir)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
NCT00916474 / 2009-011464-11: Virology Follow up Study in Subjects Previously Treated With Telaprevir

Checkmark Data-AASLD
Nov 2011 - Nov 2011: Data-AASLD
Completed
N/A
408
US, Canada, Europe
telaprevir
Vertex Pharmaceuticals Incorporated, Tibotec Pharmaceutical Limited
Hepatitis C
12/13
12/13
ETIM, NCT01641094: Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Completed
N/A
20
Europe
Foundation for Liver Research, Janssen-Cilag B.V.
Chronic Hepatitis C
06/14
12/14
NCT01980290: Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Completed
N/A
50
Europe
Janssen Pharmaceutica N.V., Belgium
Hepatitis, Chronic
02/15
02/15
NCT01447446: An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

Completed
N/A
4442
Europe, RoW
Peg-IFN Alfa-2a, Peg-IFN Alfa-2b, Ribavirin, Boceprevir, Telaprevir
Hoffmann-La Roche
Hepatitis C, Chronic
07/15
07/15
NCT01508286 / 2010-023669-23: Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Checkmark BWG 2014: HEP3002
Aug 2014 - Aug 2014: BWG 2014: HEP3002
Checkmark BWG 2014: HEP3002
Aug 2014 - Aug 2014: BWG 2014: HEP3002
Checkmark HEP3002
More
No Longer Available
N/A
Europe, RoW
Telaprevir + peginterferon alfa + ribavirin, experimental, peginterferon alfa + ribavirin
Janssen-Cilag International NV
Hepatitis C
 
 

Download Options